Biosciences
High anti-SARS-CoV-2 IgG antibody seroprevalence among long-distance trucking crews in Kenya within one year of the COVID-19 pandemic..Kagucia, E. W.
Gitonga, J. N.
Kalu, C.
Kuya, N.
Ochieng, B.
Karia, B.
Ochomo, E.
Karani, A.
Nyagwange, J.
Mugo, D.
Karanja, H. K.
Tuju, J.
Mutiso, A.
Maroko, H.
Okubi, L.
Maitha, E.
Mukabi, D.
The TDA SARS-CoV-2 Serosurveillance Team.
Aman, R.
Mwangangi, M.
Amoth, P.
Kasera, K.
Ng’ang’a, W.
Nyaguara, A.
Voller, S.
Otiende, M.
Bottomley, C.
Agoti, C. N.
Ochola-Oyier, L. I.
Adetifa, I . M. O.
Etyang, A. O.
Gallagher, K. E.
Uyoga, S.
Barasa, E.
Bejon, P.
Tsofa, B.
Agweyu, A.
Warimwe, G. M.
Scott, J. A. G.
1st International Conference on Public Health in Africa (CPHIA), (2021). :
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations..Nyagwange, J.
Kutima, B.
Mwai, K.
Karanja, H. K.
Gitonga, J. N.
Mugo, D.
Uyoga, S.
Tuju, J.
Ochola-Oyier, L. I.
Ndungu, F.
Bejon, P.
Agweyu, A.
Adetifa, I. M. O.
Scott, J. A. G.
Warimwe, G. M.
1st International Conference on Public Health in Africa (CPHIA), (2021). :
All-cause and cause-specific mortality in Kilifi Health and Demographic Surveillance System, in Kenya in the period of the COVID-19 pandemic..Otiende, M.
Nyagura, A.
Bottomley, C.
Walumbe, D.
Mochama, G.
Amadi, D.
Nyundo, C.
Kagucia, W.
Etyang, A. O.
Adetifa, I. M. O.
Maitha, E.
Chondo, E.
Nzomo, E.
Aman, R.
Mwangangi, M.
Amoth, P.
Wangari, N.
Barasa, E.
Mwangangi, J.
Bejon, P.
Agweyu, A.
Williams, T. N.
Scott, J. A. G.
1st International Conference on Public Health in Africa (CPHIA), (2021). :
Prevalence of anti-SARS-CoV-2 IgG antibodies among Kenyan blood donors between June and August 2021..Uyoga, S.
Otiende, M.
Adetifa, I. M. O.
Karanja, H. K.
Gitonga, J.
Mugo, D.
Makale, J.
Tawa, B.
Singilai, A.
Nyagwange, J.
Tuju, J.
Aman, R.
Mwangangi, M.
Amoth, P.
Kasera, K.
Ng’ang’a, W.
Kilonzo, N.
Chege, E.
Yegon, C.
Rotich, T.
Orgut, I.
Kagucia, E. W.
Gallagher, K. E.
Etyang, A.
Voller, S.
Bottomley, C.
Lambe, T.
Wright, D.
Tsofa, B.
Mwangangi, J.
Barasa, E.
Bejon, P.
Ochola-Oyier, L. I.
Warimwe, G. M.
Scott, J. A. G.
Agweyu, A.
1st International Conference on Public Health in Africa (CPHIA), (2021). :
An optimization of four SARS-CoV-2 qRT-PCR assays in a Kenyan laboratory to support the national COVID-19 rapid response teams.Mohammed, K. S.
de Laurent, Z. R.
Omuoyo, D. O.
Lewa, C.
Gicheru, E.
Cheruiyot, R.
Bartilol, B.
Mutua, S.
Musyoki, J.
Gumba, H.
Mwacharo, J.
Riako, D.
Mwangi, S. J.
Gichuki, B. M.
Nyamako, L.
Karani, A.
Karanja, H.
Mugo, D.
Gitonga, J. N.
Njuguna, S.
Gumbi, W.
Tawa, B.
Tendwa, M.
Cheruiyot, W.
Sein, Y.
Nyambu, J. K.
Patta, S. O.
Thani, T. S.
Maitha, E. K.
Kitole, B.
Mwakinangu, M. S.
Muslih, B. S.
Otieno, J. O.
Nyiro, J. U.
Kiyuka, P.
Ndwiga, L.
Wamae, K.
Kimani, D.
Makale, J.
Morobe, J. M.
Osoti, V.
Lambisia, A. W.
Odundo, C.
Mwarumba, S.
Mutunga, M.
Bejon, P.
Tsofa, B.
Agoti, C. N.
Ochola-Oyier, L. I.
Wellcome Open Res, (2020). 5:162
Funding and COVID-19 research priorities - are the research needs for Africa being met?.Antonio, E.
Alobo, M.
Tufet Bayona, M.
Marsh, K.
Norton, A.
AAS Open Res, (2020). 3:56
Antibody Responses to Crude Gametocyte Extract Predict Plasmodium falciparum Gametocyte Carriage in Kenya.Omondi, B. R.
Muthui, M. K.
Muasya, W. I.
Orindi, B.
Mwakubambanya, R. S.
Bousema, T.
Drakeley, C.
Marsh, K.
Bejon, P.
Kapulu, M. C.
Front Immunol, (2020). 11:609474
Author Correction: Investigating the drivers of the spatio-temporal patterns of genetic differences between Plasmodium falciparum malaria infections in Kilifi County, Kenya.Malinga, J.
Mogeni, P.
Omedo, I.
Rockett, K.
Hubbart, C.
Jeffreys, A.
Williams, T. N.
Kwiatkowski, D.
Bejon, P.
Ross, A.
Sci Rep, (2020). 10:22416
Plasma calprotectin as a biomarker of mortality at antiretroviral treatment initiation in advanced HIV - pilot study.Kamau, F. W.
Gwela, A.
Nyerere, A. K.
Riitho, V.
Njunge, J. M.
Ngari, M. M.
Prendergast, A. J.
Berkley, J. A.
Wellcome Open Res, (2020). 5:46
Malaria parasites hide in plain sight in the dry season.Bejon, P.
Nat Med, (2020). 26:1816-1818
Building momentum for malaria vaccine research and development: key considerations.Chitnis, C. E.
Schellenberg, D.
Vekemans, J.
Asturias, E. J.
Bejon, P.
Collins, K. A.
Crabb, B. S.
Herrera, S.
Laufer, M.
Rabinovich, N. R.
Roestenberg, M.
Shearley, A.
Tinto, H.
Wentworth, M.
O'Brien, K.
Alonso, P.
Malar J, (2020). 19:421
Trends in health workers' compliance with outpatient malaria case-management guidelines across malaria epidemiological zones in Kenya, 2010-2016.Amboko, B.
Stepniewska, K.
Macharia, P. M.
Machini, B.
Bejon, P.
Snow, R. W.
Zurovac, D.
Malar J, (2020). 19:406
Evaluating the impact of larviciding with Bti and community education and mobilization as supplementary integrated vector management interventions for malaria control in Kenya and Ethiopia.Mutero, C. M.
Okoyo, C.
Girma, M.
Mwangangi, J.
Kibe, L.
Ng'ang'a, P.
Kussa, D.
Diiro, G.
Affognon, H.
Mbogo, C. M.
Malar J, (2020). 19:390
Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan Coast.Agoti, C. N.
Mutunga, M.
Lambisia, A. W.
Kimani, D.
Cheruiyot, R.
Kiyuka, P.
Lewa, C.
Gicheru, E.
Tendwa, M.
Said Mohammed, K.
Osoti, V.
Makale, J.
Tawa, B.
Odundo, C.
Cheruiyot, W.
Nyamu, W.
Gumbi, W.
Mwacharo, J.
Nyamako, L.
Otieno, E.
Amadi, D.
Thoya, J.
Karani, A.
Mugo, D.
Musyoki, J.
Gumba, H.
Mwarumba, S.
M. Gichuki B
Njuguna, S.
Riako, D.
Mutua, S.
Gitonga, J. N.
Sein, Y.
Bartilol, B.
Mwangi, S. J.
O. Omuoyo D
M. Morobe J
de Laurent, Z. R.
Bejon, P.
Ochola-Oyier, L. I.
Tsofa, B.
Wellcome Open Res, (2020). 5:186
Modeling a Pandemic (COVID-19) Management Strategy for Urban Slums Using Social Geometry Framework.Onditi, F.
Obimbo, M.
Muchina, S. K.
Nyadera, I.
Eur J Dev Res, (2020). 32:1450-1475
Profiles of Plasmodium falciparum infections detected by microscopy through the first year of life in Kintampo a high transmission area of Ghana.Botwe, A. K.
Owusu-Agyei, S.
Asghar, M.
Hammar, U.
Oppong, F. B.
Gyaase, S.
Dosoo, D.
Jakpa, G.
Boamah, E.
Twumasi, M. F.
Osier, F.
Farnert, A.
Asante, K. P.
PLoS One, (2020). 15:e0240814
The relationship between facility-based malaria test positivity rate and community-based parasite prevalence.Kamau, A.
Mtanje, G.
Mataza, C.
Malla, L.
Bejon, P.
Snow, R. W.
PLoS One, (2020). 15:e0240058
The global response to the COVID-19 pandemic: how have immunology societies contributed?.Osier, F.
Ting, J. P. Y.
Fraser, J.
Lambrecht, B. N.
Romano, M.
Gazzinelli, R. T.
Bortoluci, K. R.
Zamboni, D. S.
Akbar, A. N.
Evans, J.
Brown, D. E.
Patel, K. D.
Wu, Y.
Perez, A. B.
Perez, O.
Kamradt, T.
Falk, C.
Barda-Saad, M.
Ariel, A.
Santoni, A.
Annunziato, F.
Cassatella, M. A.
Kiyono, H.
Chereshnev, V.
Dieye, A.
Mbow, M.
Mbengue, B.
Niang, M. D. S.
Suchard, M.
Nat Rev Immunol, (2020). 20:594-602
Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan-based malaria infection study.Jao, I.
Marsh, V.
Che Chi, P.
Kapulu, M.
Hamaluba, M.
Molyneux, S.
Bejon, P.
Kamuya, D.
Bioethics, (2020). 34:819-832
Editorial: Regulation of Immunity to Parasitic Infections Endemic to Africa.Osier, F.
Uzonna, J. E.
Front Immunol, (2020). 11:1159